Lupin launches generic Ancobon capsules in US

Lupin logo

 

Lupin has launched Flucytosine capsules and received USFDA approval. The Flucytosine capsule is sused to treat serious infections, in the American market.

The company has launched its generic product in the strengths of 250 mg and 500 mg.

Flucytosine capsules have annual sales of around USD 48 million in the US, as per the latest IMS sales data.

Yash Ved
Yash Ved is a Senior Correspondent at NewsBarons and comes with a decade of experience across leading online and offline publications. A keen observer of the stock index movement, Yash also likes covering Real Estate and the BFSI sector. A financial management and Journalism student, Yash believes learning as a continuous journey and enjoys following the IT and the Pharmaceutical industry and has penned many articles on the subjects.
yash@newsbarons.com